Skip to main content
Premium Trial:

Request an Annual Quote

Protein Discovery, Roch Kelly, Nina Fedoroff, David Harvey, Lee McCollum, Jai Nagarkatti, Avi Nash, William O Neil, Pedro Reinhard, Timothy Sear, Dean Spatz, Barrett Toan, Remco van Soest


New Products

Protein Discovery introduced this week PPS Silent Surfactant, an acid-cleavable detergent for cell membrane disruption and protein solubilization. According to the company, the new reagent offers the same detergent properties as conventional surfactants, but when it is no longer needed, it degrades into easily removed compounds with no detergent activity, instead of retaining foaming and other detergent properties that interfere with the final stages of mass spectrometry sample preparation.


Movers & Shakers

Protedyne has tapped Roch Kelly as chief operating officer. Kelly will head the company's manufacturing, purchasing, customer care, and human resources departments.

Kelly was most recently vice president of clinical operations, North America and worldwide business operations, for Paraxel International. Prior to that, he was executive director of manufacturing operations at Chiron Diagnostics.

He holds a BS in Finance from Miami University and an MBA from Syracuse University.

Sigma-Aldrich re-elected several directors at its annual shareholders meeting last week: Nina Fedoroff, David Harvey, Lee McCollum, Jai Nagarkatti, Avi Nash, William O'Neil, Pedro Reinhard, Timothy Sear, Dean Spatz, and Barrett Toan.

Remco van Soest has joined Eksigent Technologies as product manager of the company's NanoLC HPLC systems. In this role, he will lead development of tools for proteomics and biomarker discovery, and will be responsible for marketing the company's NanoLC-1D Plus and NanoLC-2D proteomics systems.

Most recently, van Soest was technical manager at Dionex. Prior to that, he was research scientist at LC Packings. He holds an MS in analytical chemistry from Vrije Universiteit the Netherlands.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.